Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-04-18 00:00:00 ET · period of report 2024-04-16 · accession 0001601830-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-18 | 2024-04-16+ | RXRX | Secora Michael | CFO | S - Sale+OE | $7.63 | -48.1K | 1.22M | -4% | -$367.0K |
| DM | 2024-04-18 | 2024-04-16+ | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.24M | +6% | +$166.5K |
| DM | 2024-04-18 | 2024-04-16+ | RXRX | Secora Michael | CFO | M - OptEx | $0.00 | -75.0K | 810.1K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-04-17 | S | D | 23,124 | $7.58 | 1,231,055 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $7.44 to $7.70 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2024-04-17 | M | A | 37,500 | $2.22 | 1,254,179 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-04-16 | S | D | 25,000 | $7.67 | 1,216,679 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $7.54 to $7.77 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2024-04-16 | M | A | 37,500 | $2.22 | 1,241,679 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-04-16 | M | D | 37,500 | $0.00 | 847,635 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F4) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-04-17 | M | D | 37,500 | $0.00 | 810,135 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F4) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |